IONS logo

Ionis Pharmaceuticals (IONS)

Profile

Full Name

Ionis Pharmaceuticals, Inc.

Ticker Symbol

IONS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 17, 1991

Indexes

Not included

Website

http://www.ionis.com

Employees

1069

Key Details

Price

$28.71(+2.92%)

Market cap

$4.56B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$705.14M(-10.48% YoY)

Annual EPS

-$3.04(-18.75% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$28.71
IONS price is $28.71

30-Day Relative Volume

1.22
IONS 30-day relative volume is 1.22

Price Performance

Price Today change

+2.92%
IONS price is up +2.92% today

Price YTD change

-17.86%
IONS price is down -17.86% since January 1st

Price 1-year change

-31.21%
IONS price is down -31.21% year-on-year

Price 3-year change

-29.91%
IONS price is down -29.91% over the past 3 years

Price Range

Price All-time high

$86.58
IONS price is currently -66.83% below its historical high of $86.58

Price 3-year low

$23.95
IONS price is currently +19.90% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.56B
IONS market capitalization is $4.56 billion

Market cap 3-year change

-21.4%
IONS market capitalization is down -21.4% over the past 3 years

Market cap All-time high

$12.04B
IONS market capitalization is currently -62.08% below its historical high of $12.04 billion

Market cap sector rank

88.74%
IONS market capitalization is higher than 88.74% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+9%
IONS shares outstanding is up +9% year-on-year

Shares Outstanding 3-Year Change

+12.14%
IONS shares outstanding is up +12.14% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.83
IONS beta is 0.83

200-day SMA

$38.62
IONS price is currently -25.65% below its 200-day simple moving average

50-day SMA

$31.45
IONS price is currently -8.70% below its 50-day simple moving average

RSI

42.28
IONS 14-day relative strength index is 42.28

Volume

1.22
IONS 30-day relative volume is 1.22

ATR

$1.79
IONS average true range is $1.79

10-day Historical Volatility

94.67%
IONS 10-day historical volatility is 94.67%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$705.14M
IONS annual revenue is $705.14 million

Revenue Analysts estimate

$687.24M
IONS annual revenue is currently +2.60% higher than the consensus analysts' forecast

Revenue 1-year change

-10.48%
IONS annual revenue is down -10.48% year-on-year

Revenue Sector rank

77.6%
IONS annual revenue is higher than 77.6% of companies in Healthcare sector

EPS

EPS

-$3.04
IONS annual earnings per share is -$3.04

EPS Analysts estimate

-$2.85
IONS annual earnings per share is currently +6.82% higher than the consensus analysts' forecast

EPS 1-year change

-18.75%
IONS annual earnings per share is down -18.75% year-on-year

EPS Sector rank

28.98%
IONS annual earnings per share is higher than 28.98% of companies in Healthcare sector

Profit

Gross profit

$693.92M
IONS annual gross profit is $693.92 million

Gross margin

98.41%
IONS annual gross profit margin is 98.41%

Operating profit

-$475.11M
IONS annual operating income is -$475.11 million

Operating margin

-67.38%
IONS annual operating profit margin is -67.38%

Net income

-$453.90M
IONS annual net profit is -$453.90 million

Net margin

-64.37%
IONS annual net profit margin is -64.37%

Expenses

Total expenses

$1.18B
IONS annual total expenses is $1.18 billion

Operating expenses

$1.17B
IONS annual total operating expenses is $1.17 billion

Cost of goods sold

$11.21M
IONS annual cost of goods sold is $11.21 million

Selling, general & administrative expenses

$267.50M
IONS annual SGA is $267.50 million

Depreciation and amortization

$21.99M
IONS annual depreciation & amortization is $21.99 million

Interest expense

$84.36M
IONS annual interest expense is $84.36 million

Income tax

-$6.17M
IONS annual income tax is -$6.17 million

EBIT & EBITDA

EBIT

-$375.71M
IONS annual earnings before interest & taxes is -$375.71 million

EBITDA

-$353.72M
IONS annual EBITDA is -$353.72 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.00B
IONS annual total assets is $3.00 billion

Non current assets

$383.38M
IONS annual long term assets is $383.38 million

Current assets

$2.62B
IONS annual total current assets is $2.62 billion

Cash and cash equivalents

$242.08M
IONS annual cash & cash equivalents is $242.08 million

Accounts receivable

-
IONS annual accounts receivable value is unknown

Inventory

$12.51M
IONS annual inventory is $12.51 million

Liabilities

Total liabilities

$2.42B
IONS annual total liabilities is $2.42 billion

Long term liabilities

$2.11B
IONS annual total long term liabilities is $2.11 billion

Current liabilities

$309.32M
IONS annual total current liabilities is $309.32 million

Accounts payable

$42.96M
IONS annual accounts payable is $42.96 million

Debt

Total debt

$1.42B
IONS annual total debt is $1.42 billion

Total debt 1-year change

-2.54%
IONS annual total debt is down -2.54% year-on-year

Long term debt

$1.41B
IONS annual long term debt is $1.41 billion

Short term debt

$9.28M
IONS annual short term debt is $9.28 million

Equity & Capital

Shareholders equity

$588.35M
IONS annual stockholders equity is $588.35 million

Book value

$588.35M
IONS annual book value is $588.35 million

Retained earnings

-$2.25B
IONS annual retained earnings is -$2.25 billion

Working capital

$2.31B
IONS annual working capital is $2.31 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$500.95M
IONS annual cash flow from operations is -$500.95 million

Cash from operations 1-year change

-62.9%
IONS annual cash flow from operations is down -62.9% year-on-year

Cash from investing

-$134.03M
IONS annual cash flow from investing activities is -$134.03 million

Cash from investing 1-year change

+37.41%
IONS annual cash flow from investing activities is up +37.41% year-on-year

Cash from financing

$478.06M
IONS annual cash flow from financing activities is $478.06 million

Cash from financing 1-year change

-25.78%
IONS annual cash flow from financing activities is down -25.78% year-on-year

CAPEX

CAPEX

$50.34M
IONS annual capital expenditures is $50.34 million

CAPEX 1-year change

+79.72%
IONS annual capital expenditures is up +79.72% year-on-year

Free Cash Flow

Free cash flow

-$551.29M
IONS annual free cash flow is -$551.29 million

Free cash flow 1-year change

-64.31%
IONS annual free cash flow is down -64.31% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

98.41%
IONS annual gross profit margin is 98.41%

Operating margin

-67.38%
IONS annual operating profit margin is -67.38%

Net margin

-64.37%
IONS annual net profit margin is -64.37%

ROA & ROE

ROA

-15.15%
IONS annual return on assets is -15.15%

ROE

-93.10%
IONS annual return on equity is -93.10%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IONS price to earnings ratio value is unknown

PE ratio Sector rank

-
IONS price to earnings ratio is unknown

PB Ratio

PB ratio

7.76
IONS price to book ratio is 7.76

PB ratio Sector rank

90.05%
IONS price to book ratio is higher than 90.05% of companies in Healthcare sector

PS Ratio

PS ratio

6.47
IONS price to sales ratio is 6.47

PS ratio Sector rank

71.92%
IONS price to sales ratio is higher than 71.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$5.74B
IONS enterprise value is $5.74 billion

Enterprise value Sector rank

88.93%
IONS enterprise value is higher than 88.93% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-16.29
IONS EV/EBITDA is -16.29

EV/EBITDA Sector rank

7.47%
IONS EV/EBITDA is higher than 7.47% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.47
IONS annual current ratio is 8.47

Quick ratio

8.43
IONS annual quick ratio is 8.43

Leverage

Debt to equity

2.13
IONS annual debt to equity ratio is 2.13

Interest coverage ratio

-4.45
IONS annual interest coverage ratio is -4.45

Risk & Stability

Piotroski F-Score

1
IONS piotroski f-score is 1

Altman Z-Score

0.83
IONS altman z-score is 0.83

Analyst ratings

Recent major analysts updates

Apr 8, 25 Needham
Buy
Apr 7, 25 HC Wainwright & Co.
Buy
Apr 3, 25 Guggenheim
Buy
Mar 31, 25 Redburn Atlantic
Neutral
Mar 24, 25 JP Morgan
Neutral
Mar 11, 25 JP Morgan
Neutral
Feb 20, 25 RBC Capital
Outperform
Feb 20, 25 Needham
Buy
Feb 20, 25 Citigroup
Buy
Feb 20, 25 BMO Capital
Market Perform

Institutional Ownership

Similar stocks

ALKS logo
Alkermes (ALKS)
INSP logo
Inspire Medical Systems (INSP)
CYTK logo
Cytokinetics Incorporated (CYTK)
ELAN logo
Elanco Animal Health Incorporated (ELAN)
GRFS logo
Grifols SA (GRFS)
ADMA logo
ADMA Biologics (ADMA)
NUVL logo
Nuvalent (NUVL)
KRYS logo
Krystal Biotech (KRYS)
AXSM logo
Axsome Therapeutics (AXSM)
  • What is the ticker symbol for Ionis Pharmaceuticals?
  • Does Ionis Pharmaceuticals pay dividends?
  • What sector is Ionis Pharmaceuticals in?
  • What industry is Ionis Pharmaceuticals in?
  • What country is Ionis Pharmaceuticals based in?
  • When did Ionis Pharmaceuticals go public?
  • Is Ionis Pharmaceuticals in the S&P 500?
  • Is Ionis Pharmaceuticals in the NASDAQ 100?
  • Is Ionis Pharmaceuticals in the Dow Jones?
  • When was Ionis Pharmaceuticals's last earnings report?
  • When does Ionis Pharmaceuticals report earnings?
  • Should I buy Ionis Pharmaceuticals stock now?

What is the ticker symbol for Ionis Pharmaceuticals?

The ticker symbol for Ionis Pharmaceuticals is NASDAQ:IONS

Does Ionis Pharmaceuticals pay dividends?

No, Ionis Pharmaceuticals does not pay dividends

What sector is Ionis Pharmaceuticals in?

Ionis Pharmaceuticals is in the Healthcare sector

What industry is Ionis Pharmaceuticals in?

Ionis Pharmaceuticals is in the Biotechnology industry

What country is Ionis Pharmaceuticals based in?

Ionis Pharmaceuticals is headquartered in United States

When did Ionis Pharmaceuticals go public?

Ionis Pharmaceuticals's initial public offering (IPO) was on May 17, 1991

Is Ionis Pharmaceuticals in the S&P 500?

No, Ionis Pharmaceuticals is not included in the S&P 500 index

Is Ionis Pharmaceuticals in the NASDAQ 100?

No, Ionis Pharmaceuticals is not included in the NASDAQ 100 index

Is Ionis Pharmaceuticals in the Dow Jones?

No, Ionis Pharmaceuticals is not included in the Dow Jones index

When was Ionis Pharmaceuticals's last earnings report?

Ionis Pharmaceuticals's most recent earnings report was on Feb 19, 2025

When does Ionis Pharmaceuticals report earnings?

The next expected earnings date for Ionis Pharmaceuticals is May 7, 2025

Should I buy Ionis Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page